Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Radha Rajasingham

Showing results (31-40 of 108) with videos related to

Pageof 11
Sort By:
Medical Mycology|January 13, 2022
Cost-effectiveness of single-dose AmBisome pre-emptive treatment for the prevention of cryptococcal meningitis in African low and middle-income countriesRadha Rajasingham, Elizabeth Nalintya, Dennis M Israelski, et al.
Plos One|June 2, 2026
Change in plasma cryptococcal antigen titers in Uganda among outpatients with advanced HIV disease from 2017 to 2022 with rollout of national cryptococcal screeningAlexandra Poeschla, Abduljewad Wele, Elizabeth Nalintya, et al.
Plos One|August 1, 2014
Performance of cryptococcal antigen lateral flow assay using saliva in Ugandans with CD4 <100Richard Kwizera, Joyce Nguna, Agnes Kiragga, et al.
Journal of Clinical and Translational Science|February 22, 2024
Progress toward realizing the promise of decentralized clinical trialsMatthew W McCarthy, Christopher J Lindsell, Radha Rajasingham, et al.
AIDS Patient Care and Stds|November 11, 2011
A systematic review of behavioral and treatment outcome studies among HIV-infected men who have sex with men who abuse crystal methamphetamineRadha Rajasingham, Matthew J Mimiaga, Jaclyn M White, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Inadequacy of High-Dose Fluconazole Monotherapy Among Cerebrospinal Fluid Cryptococcal Antigen (CrAg)-Positive Human Immunodeficiency Virus-Infected Persons in an Ethiopian CrAg Screening ProgramTafese Beyene, Anteneh G Zewde, Abera Balcha, et al.
Open Forum Infectious Diseases|September 15, 2020
A Systematic Review of Treatment and Outcomes of Pregnant Women With COVID-19-A Call for Clinical TrialsKatelyn A Pastick, Melanie R Nicol, Elizabeth Smyth, et al.
Metabolic Brain Disease|January 9, 2014
Predictors of neurocognitive outcomes on antiretroviral therapy after cryptococcal meningitis: a prospective cohort studyRenee Donahue Carlson, Melissa A Rolfes, Kate E Birkenkamp, et al.
Journal of Clinical Microbiology|February 7, 2020
Evaluation of Serum Cryptococcal Antigen Testing Using Two Novel Semiquantitative Lateral Flow Assays in Persons with Cryptococcal AntigenemiaCaleb Skipper, Kiiza Tadeo, Emily Martyn, et al.
Plos One|January 11, 2019
Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysisRadha Rajasingham, David B Meya, Gregory S Greene, et al.
Pageof 11

Showing results (31-40 of 108) with videos related to

Sort By:
Pageof 11
Medical Mycology|January 13, 2022
Cost-effectiveness of single-dose AmBisome pre-emptive treatment for the prevention of cryptococcal meningitis in African low and middle-income countriesRadha Rajasingham, Elizabeth Nalintya, Dennis M Israelski, et al.
Plos One|June 2, 2026
Change in plasma cryptococcal antigen titers in Uganda among outpatients with advanced HIV disease from 2017 to 2022 with rollout of national cryptococcal screeningAlexandra Poeschla, Abduljewad Wele, Elizabeth Nalintya, et al.
Plos One|August 1, 2014
Performance of cryptococcal antigen lateral flow assay using saliva in Ugandans with CD4 <100Richard Kwizera, Joyce Nguna, Agnes Kiragga, et al.
Journal of Clinical and Translational Science|February 22, 2024
Progress toward realizing the promise of decentralized clinical trialsMatthew W McCarthy, Christopher J Lindsell, Radha Rajasingham, et al.
AIDS Patient Care and Stds|November 11, 2011
A systematic review of behavioral and treatment outcome studies among HIV-infected men who have sex with men who abuse crystal methamphetamineRadha Rajasingham, Matthew J Mimiaga, Jaclyn M White, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Inadequacy of High-Dose Fluconazole Monotherapy Among Cerebrospinal Fluid Cryptococcal Antigen (CrAg)-Positive Human Immunodeficiency Virus-Infected Persons in an Ethiopian CrAg Screening ProgramTafese Beyene, Anteneh G Zewde, Abera Balcha, et al.
Open Forum Infectious Diseases|September 15, 2020
A Systematic Review of Treatment and Outcomes of Pregnant Women With COVID-19-A Call for Clinical TrialsKatelyn A Pastick, Melanie R Nicol, Elizabeth Smyth, et al.
Metabolic Brain Disease|January 9, 2014
Predictors of neurocognitive outcomes on antiretroviral therapy after cryptococcal meningitis: a prospective cohort studyRenee Donahue Carlson, Melissa A Rolfes, Kate E Birkenkamp, et al.
Journal of Clinical Microbiology|February 7, 2020
Evaluation of Serum Cryptococcal Antigen Testing Using Two Novel Semiquantitative Lateral Flow Assays in Persons with Cryptococcal AntigenemiaCaleb Skipper, Kiiza Tadeo, Emily Martyn, et al.
Plos One|January 11, 2019
Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysisRadha Rajasingham, David B Meya, Gregory S Greene, et al.
Pageof 11